Cart
sales@molnova.com
SGA360
CAS No. 680611-86-3
SGA360( —— )
Catalog No. M24693 CAS No. 680611-86-3
SGA360 is a selective aryl hydrocarbon (Ah) receptor modulator. It exhibits anti-inflammatory properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 125 | In Stock |
|
| 10MG | 205 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 446 | In Stock |
|
| 100MG | 647 | In Stock |
|
| 500MG | 1341 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSGA360
-
NoteResearch use only, not for human use.
-
Brief DescriptionSGA360 is a selective aryl hydrocarbon (Ah) receptor modulator. It exhibits anti-inflammatory properties.
-
DescriptionSGA360 is a selective aryl hydrocarbon (Ah) receptor modulator. It exhibits anti-inflammatory properties.
-
In Vitro——
-
In VivoSGA360 exhibits anti-inflammatory activity in vivo.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptoraryl hydrocarbon receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number680611-86-3
-
Formula Weight362.3
-
Molecular FormulaC19H17F3N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCOC1=CC(=C(C=C1)C2=NN(C3=C2C=CC=C3C(F)(F)F)CC=C)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Muku G E , Lahoti T S , Murray I A , et al. Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses[J]. Laboratory Investigation, 2017.
molnova catalog
related products
-
SBI-477
SBI-477 is a chemical probe stimulated insulin signaling by deactivating the transcription factor MondoA. SBI-477 coordinately inhibits triacylglyceride (TAG) synthesis and enhances basal glucose uptake in human skeletal myocytes.
-
Thalidomide-NH-PEG1-...
Thalidomide-NH-PEG1-NH2 hydrochloride is a synthetic E3 ligase ligand-linker conjugate that incorporates the Thalidomide-based cereblon ligand and a linker.
-
Incensole acetate
Incensole acetate is a novel anti-inflammatory compound that inhibits NF-κB activation.
